Description
Aimovig (erenumab) is a prescription medication that is used to prevent migraines. It is a human monoclonal antibody that blocks the calcitonin gene-related peptide (CGRP) receptor, which is involved in migraine attacks. It is administered as a once-a-month injection.
Uses:
Aimovig is used to prevent migraines in adults who experience episodic or chronic migraines. It has been found to reduce the frequency and severity of migraines.
Storage Conditions:
Aimovig should be stored in a refrigerator at a temperature between 2℃ and 8℃ (36℉ to 46℉). It should be protected from light and should not be frozen. Patients should not use the medication if it has been exposed to temperatures above 25℃ (77℉) or if it has been frozen.
Mechanism of Action:
Aimovig blocks the CGRP receptor, which is involved in the inflammation and dilation of blood vessels in the brain that occurs during migraine attacks. By blocking the receptor, Aimovig reduces the frequency and severity of migraines.
How to Use:
Aimovig is administered as a monthly injection. The medication comes in a prefilled autoinjector or a prefilled syringe. The injection is given under the skin in the abdomen, thigh, or upper arm. Patients should follow the instructions provided by their healthcare provider on how to inject the medication.
Precautions:
Patients should inform their healthcare provider of any allergies, medical conditions, or medications they are currently taking before taking Aimovig. The medication may cause an increased risk of infection and patients should be monitored for signs of infection. Patients should not receive Aimovig if they are allergic to erenumab or any of its components.
Drug Interactions:
There are no known drug interactions with Aimovig. However, patients should inform their healthcare provider of any medications they are taking, including over-the-counter medications, vitamins, and supplements before taking Aimovig.
Contraindications:
Patients should not receive Aimovig if they are allergic to erenumab or any of its components.
Overdose:
There are no known symptoms of Aimovig overdose.
Adverse Reactions:
The most common side effects associated with Aimovig include injection site reactions, such as pain, redness, or swelling at the injection site. Patients may also experience constipation and muscle pain. Patients should report any adverse reactions to their healthcare provider immediately.
Overall, Aimovig is a prescription medication used to prevent migraines. It blocks the CGRP receptor, reducing the frequency and severity of migraines. It is administered as a monthly injection and should be stored in a refrigerator. Patients should inform their healthcare provider of any allergies, medical conditions, or medications they are taking before taking Aimovig. The medication may cause injection site reactions, constipation, and muscle pain. It is contraindicated in patients who are allergic to erenumab or any of its components.
Reviews
There are no reviews yet.